𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metastatic prostatic adenocarcinoma to the orbit diagnosed by prostate-specific antigen staining

✍ Scribed by Peng, K-L; Kao, S-C; Yang, C-F; Kau, H-C; Tsai, C-C; Hsu, W-M


Book ID
110037140
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
151 KB
Volume
22
Category
Article
ISSN
0950-222X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Paget's disease of the scrotum: a case e
✍ Allan; Mclaren; Aldridge πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 373 KB

A 75-year-old man with carcinoma of the prostate presented with a pruritic, erythematous plaque involving the scrotal skin. Histological examination revealed extramammary Paget's disease. The intraepidermal tumour cells expressed prostate-specific antigen in keeping with a prostatic origin.

Immunoreactivity for prostate-specific a
✍ Sauvageot, Jurgita; Epstein, Jonathan I. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 33 KB πŸ‘ 2 views

## Background: Although, in general, immunoperoxidase staining for prostate-specific antigen (psa) and prostate-specific acid phosphatase (psap) cannot distinguish between benign and malignant prostatic epithelium, immunoreactivity of these antigens may be helpful in predicting prognosis of prostat

Ectopic production of prostate specific
✍ H. Yu; Dr. E. P. Diamandis; M. Levesque; P. Sismondi; P. Zola; D. Katsaros πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 266 KB

We have recently reported that about 30% of breast tumors produce prostate specific antigen (PSA). We examined here, 99 primary ovarian cancer tumors and found relatively low levels of PSA in only three tumors. One patient with metastatic ovarian cancer from a primary breast tumor, produced relative

Free-to-total prostate-specific antigen
✍ Ward, John F.; Johnstone, Peter A.S.; Kane, Christopher J. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 2 views

## Background and Objectives: The purpose of this study was to evaluate free-to-total prostate-specific antigen (PSA) ratios after definitive external beam radiation therapy for men with adenocarcinoma of the prostate (CaP). Methods: A prospective evaluation of percent free PSA in men following de